Renata Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other
pharmaceutical manufacturers in Asia:
Nippon Chemiphar Co., Ltd.
sales of 31.76 billion Japanese Yen [US$288.98 million]
of which 96%
was Pharmaceutical Business),
(21.52 billion Indian Rupees [US$289.40 million]
of which 100%
was Pharmaceuticals.), and
Tci Co Ltd
based in TAIWAN
(8.22 billion Taiwanese Dollars [US$288.99 million]
of which 72%
Renata Limited reported sales of 24.67 billion Bangladeshi Taka (US$291.16 million)
June of 2020.
increase of 8.2%
versus 2019, when the company's sales were 22.81 billion Bangladeshi Taka.
Sales at Renata Limited have increased during each of the previous five years
(and since 2015, sales have increased a total of 84%).